1. Hypofibrinogenemia as a clue in the presumptive diagnosis of acute promyelocytic leukemia. (November 2016) Authors: Lou, Yinjun; Suo, Shanshan; Tong, Hongyan; Qian, Wenbin; Mai, Wenyuan; Meng, Haitao; Yu, Wenjuan; Wei, Juyin; Jin, Jie Journal: Leukemia research Issue: Volume 50(2016:Nov.) Page Start: 11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Improved long‐term survival in all Sanz risk patients of newly diagnosed acute promyelocytic leukemia treated with a combination of retinoic acid and arsenic trioxide‐based front‐line therapy. Issue 3 (3rd June 2018) Authors: Lou, Yinjun; Lu, Ying; Zhu, Zhijuan; Ma, Yafang; Suo, Shanshan; Wang, Yungui; Chen, Dong; Tong, Hongyan; Qian, Wenbin; Meng, Haitao; Mai, Wenyuan; Yu, Wenjun; Xu, Weilai; Wang, Lei; Mao, Liping; Pei, Renzhi; Jin, Jie Journal: Hematological oncology Issue: Volume 36:Issue 3(2018) Page Start: 584 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Long‐term efficacy of low‐dose all‐trans retinoic acid plus minimal chemotherapy induction followed by the addition of intravenous arsenic trioxide post‐remission therapy in newly diagnosed acute promyelocytic leukaemia. Issue 1 (20th August 2013) Authors: Lou, Yinjun; Qian, Wenbin; Meng, Haitao; Mai, Wenyuan; Tong, Hongyan; Tong, Yin; Huang, Jian; Jin, Jie Journal: Hematological oncology Issue: Volume 32:Issue 1(2014:Mar.) Page Start: 40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor priming regimen versus idarubicin plus cytarabine regimen as induction therapy for older patients with acute myeloid leukemia. Issue 6 (June 2015) Authors: Jin, Jie; Chen, Jian; Suo, Shanshan; Qian, Wenbin; Meng, Haitao; Mai, Wenyuan; Tong, Hongyan; Huang, Jian; Yu, Wenjuan; Wei, Juyin; Lou, Yinjun Journal: Leukemia & lymphoma Issue: Volume 56:Issue 6(2015:Jun.) Page Start: 1691 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Prognostic factors of patients with newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide-based frontline therapy. Issue 9 (September 2015) Authors: Lou, Yinjun; Ma, Yafang; Suo, Shanshan; Ni, Wanmao; Wang, Yungui; Pan, Hanzhang; Tong, Hongyan; Qian, Wenbin; Meng, Haitao; Mai, Wenyuan; Huang, Jian; Yu, Wenjuan; Wei, Juyin; Mao, Liping; Jin, Jie Journal: Leukemia research Issue: Volume 39:Issue 9(2015:Sep.) Page Start: 938 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The risk of hepatitis B virus reactivation and the role of antiviral prophylaxis in hepatitis B surface antigen negative/hepatitis B core antibody positive patients with diffuse large B-cell lymphoma receiving rituximab-based chemotherapy. Issue 4 (April 2015) Authors: Lu, Shasha; Xu, Yu; Mu, Qitian; Cao, Lihong; Chen, Jian; Zhu, Zhijuan; Lou, Yinjun; Meng, Haitao; Qian, Wenbin; Tong, Hongyan; Mai, Wenyuan; Huang, Jian; Yu, Wenjuan; Zhao, Xiaoying; Jin, Jie Journal: Leukemia & lymphoma Issue: Volume 56:Issue 4(2015:Apr.) Page Start: 1027 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial. Issue 6 (June 2022) Authors: Wang, Huafeng; Mao, Liping; Yang, Min; Qian, Pengxu; Lu, Huan; Tong, Hongyan; Xie, Wanzhuo; Zhou, De; Huang, Xin; Wang, Yungui; Xu, Gaixiang; Lu, Ying; Wei, Juying; Mai, Wenyuan; Ye, Xiujin; Meng, Haitao; Shen, Yaojia; Huang, Jian; Yu, Wenjuan; Sun, Jie Journal: Lancet Issue: Volume 9:Issue 6(2022) Page Start: e415 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗